ECP for Heart Attack and Heart Failure

ECP for Heart Failure

ECP reduces the workload of the heart and so supports patients with Heart failure. ECP has been demonstrated as a safe adjunct therapy for heart failure. Efficacy results suggest that ECP can improve exercise tolerance capacity, quality of life and functional status, both in the short term and also for a period of 6 months after completion of the EECP therapy. 

Improved Functional Performance

Improved Quality of Life

Reduce Angina

Improved Quality of Life

ECP following Heart Attack

After a heart attack, part of the heart muscle dies. By improving blood flow back through the coronary arteries ECP therapy can reduce angina and extend the time to ischaemia and increase exercise tolerance. Studies have demonstrated that ECP therapy can be offered as a safe treatment option for patients who have left ventricular dysfunction and angina pectoris.

Contact us to find out more

Click the button below and a member of the team will be right with you. If you’d rather live chat, click the live chat button.